Cengild Medical Berhad (KLSE:CENGILD)

Cengild Medical Berhad Balance Sheet

Financials in millions MYR. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	5.85	11.8	1.92	0.76	5.83	0.65
Short-Term Investments	49.53	73.45	88.5	98.27	81.24	6.35
Cash & Short-Term Investments	55.39	85.24	90.42	99.03	87.07	6.99
Cash Growth	-38.73%	-5.72%	-8.70%	13.74%	1145.04%	10.89%
Accounts Receivable	7.16	8.79	6.55	5.08	4.78	4.5
Other Receivables	2.78	1.78	0.38	0.41	0.33	0.1
Receivables	9.94	10.57	6.93	5.49	5.11	4.59
Inventory	2.08	2.05	1.72	1.38	1.15	0.94
Prepaid Expenses	-	0.57	0.33	0.26	0.4	0.13
Total Current Assets	67.41	98.44	99.39	106.17	93.74	12.65
Property, Plant & Equipment	140.65	75.62	30.2	23.89	24.35	33.32
Long-Term Investments	6.99	3.4	0.92	0	0	0
Long-Term Deferred Tax Assets	2.42	2.42	1.93	1.67	1.45	-
Other Long-Term Assets	0.44	0.61	-	-	-	-
Total Assets	217.91	180.49	132.44	131.73	119.54	45.98

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	7.58	9.42	5.15	2.59	3.52	5.3
Accrued Expenses	0.04	3.09	2.98	4.2	3.47	1.7
Short-Term Debt	-	-	-	-	-	2.02
Current Portion of Leases	2.41	2.32	2.48	1.33	1.27	0.91
Current Income Taxes Payable	0.74	1.65	0.98	0.29	0.33	0.47
Other Current Liabilities	6.38	3.58	3.17	2.98	3.07	0.54
Total Current Liabilities	17.15	20.05	14.77	11.4	11.66	10.95
Long-Term Debt	83.5	42.82	-	-	-	-
Long-Term Leases	0.62	2.41	5.67	13.6	14.93	21.25
Other Long-Term Liabilities	0.77	0.75	0.72	0.62	-	-
Total Liabilities	102.04	66.03	21.15	25.62	26.59	32.2

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	87.49	87.49	87.49	87.47	81.93	12.24
Retained Earnings	25.9	24.52	21.54	16.63	9.4	0.01
Comprehensive Income & Other	2.49	2.45	2.27	2.01	1.62	1.53
Shareholders' Equity	115.87	114.46	111.3	106.11	92.95	13.78
Total Liabilities & Equity	217.91	180.49	132.44	131.73	119.54	45.98

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	86.53	47.55	8.14	14.93	16.21	24.18
Net Cash (Debt)	-31.14	37.69	82.27	84.1	70.87	-17.19
Net Cash Growth	-	-54.18%	-2.17%	18.67%	-	-
Net Cash Per Share	-0.04	0.05	0.10	0.10	0.11	-0.03
Filing Date Shares Outstanding	832.91	832.91	832.91	832.91	818.8	600
Total Common Shares Outstanding	832.91	832.91	832.91	832.87	818.8	600
Working Capital	50.26	78.38	84.62	94.77	82.08	1.7
Book Value Per Share	0.14	0.14	0.13	0.13	0.11	0.02
Tangible Book Value	115.87	114.46	111.3	106.11	92.95	13.78
Tangible Book Value Per Share	0.14	0.14	0.13	0.13	0.11	0.02
Machinery	-	17.78	15.99	13.34	12.42	12.19
Construction In Progress	-	63.38	12.71	0.55	0.18	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error